A Smart + Strong Site
Subscribe to:
Newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

March 13, 2012

High Blood Pressure Increases Heart Attack Risk in HIV

by Tim Horn

CROI 2012 Elevated blood pressure—including levels that don’t yet meet the definition of hypertension—is associated with a “substantially greater” risk of a heart attack among people living with HIV, compared with HIV-negative controls, according to a Veterans Health Administration study reported Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections in Seattle.

Though much has been reported on lipid abnormalities, arterial inflammation and their connections to the increased risk of heart attacks among people living with HIV, little regarding the role of elevated blood pressure has been highlighted by researchers. Some studies have suggested that higher-than-normal blood pressure isn’t necessarily more common in HIV-positive people, but it’s not clear if those who do have high blood pressure are at an increased risk of a heart attack, compared with people not living with HIV.

The study reported at CROI by Kaku Armah of the University of Pittsburgh Graduate School of Public Health and his colleagues was designed to evaluate the potential associations between systolic blood pressure (SBP; the first, higher number of a reading), diastolic blood pressure (DBP; the second, lower number of the two) and heart attacks in HIV-positive and HIV-negative volunteers participating in the Veterans Aging Cohort Study (VACS). 

Armah and his team included 82,486 subjects, 27,265 of whom were HIV positive and matched for age, sex and race characteristics with 55,125 HIV-negative individuals. Patients were characterized as having normal blood pressure, prehypertension (SBP between 120 and 139 or a DBP between 80 and 89, without use of a blood pressure medication) or frank hypertension: either an SBP below 140 or a DBP below 90 with the use of blood pressure medications, or an SBP of 140 or above or a DBP of at least 90 either with or without blood pressure medication. 

SBP and DBP classifications included in the analysis were based on an average of three blood pressure readings around the time each person entered the VACS. 
After adjusting the data for other known risk factors for heart attacks—age, sex, race and ethnicity, a diabetes diagnosis, lipid levels, statin use, past or present smoking, hepatitis C coinfection, body mass index and kidney disease—HIV infection itself was associated with significant increases the relative risk of a heart attack.

It’s important to note, however, that increases in relative risk may not necessarily translate into a substantial increase in the absolute risk of a heart attack. Relative risk increases may be more meaningful for people with other known risk factors for cardiovascular disease and heart attacks; conversely, they may be less worrisome—but still worthy of discussion with health care providers—for those with few or no other risk factors. 

Looking solely at SBP measurements, HIV-positive participants with prehypertension saw their relative risk of a heart attack increase 70 percent. The relative risk more than doubled for those who met the frank hypertension criteria. These risk increases were all statistically significant when compared with the reference population—HIV-negative individuals with normal average SBP readings.

As for SBP readings in the HIV-negative subjects, the only statistically significant difference was a 60 percent increase in the relative risk of a heart attack among those with an SBP of at least 140, either with or without the use of blood pressure medications.

As for DBP measures, the relative risk of a heart attack tripled among the HIV-positive individuals with average DBP measurements of 90 or above, with or without the use of blood pressure medications. Among those with prehypertension or an average DBP below 90 while receiving blood pressure medications, the relative risk of a heart attack was doubled. These increases were all statistically significant, when compared with a reference population of HIV-negative individuals with average DBP measurements of less than 80 and not using blood pressure medications.

Looking at the HIV-negative volunteers, the increases in relative risk were only statistically significant for those with average DPB measurements below 90 while receiving blood pressure medications and those with average DBP measurements of 90 or higher. But here, the relative risk of a heart attacked increased only 50 percent and 70 percent, respectively.

“Systolic and diastolic hypertension are associated with increased acute myocardial infarction [heart attack] risk in [people living with HIV],” Armah summarized. This increased risk, he added, “is present even at prehypertensive levels.”

Treating hypertension in people living with HIV needs to be a priority, Armah concluded, just as aggressive control of high blood pressure is recommended by numerous medical associations for other groups of individuals at risk for heart attacks. “There is also a need to address prehypertension in HIV-positive patients,” he added. “Preventing progression to hypertension, notably through lifestyle medication, is important.”

Search: blood pressure, hypertension, systolic, diastolic, veterans, myocardial infarction, heart attack, MI, VACS, Armah, CROI, Seattle


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)


[Go to top]

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    adoniz89
    san dimas
    California


    Sloan1
    Dallas
    Texas


    Heartland4now
    Tacoma
    Washington


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.